Separate names with a comma.
Discussion in 'Allergan' started by anonymous, Nov 3, 2017 at 5:42 PM.
No I meant we would have been better off years ago under BS instead of DP
How so? BS is crap!
BS does what is right for shareholders. BS does what is necessary to protect the best brands like Restasis. He built to where it is today. From a leadership standpoint there is no comparison. We might not agree with every decision but we usually see why the decision was made later and we understand. His job is not the easiest one in the world but he is a top performer and would have been a welcomed edition to Allergan when DP lost control.
And believe me us shareholders are thrilled to see the stock go from $300 to $172. Being the subject of a congressional inquiry is great also!
BS lost a patent he had 7 more years on. He made a stupid decision and guess what? WE will be punished for it while he gets to keep making millions
If he were a real leader, the cost cutting would come from HIS salary because of the decision HE made. But instead our heads will roll, not his.
Where do you come up with this Bullshit?
And who are you referring to as "we?"
Do you think Brent magically started the Restasis brand at the completion of the takeover? I might remind you that was June of 2015. He's done nothing but spend the surplus that he inherited with was a great and respected company.
Kool-aid drinking fool.
This article pretty much says it all. I'm not sure who is advising BS on how to spend money but he had definitely made some questionable choices.
This is Seeking alpha dont forget. Written by wanna be Wall st people. Just sayin'
BS is arguably the worst CEO in pharma! Wonder what you will think if the board feels pressure from shareholders to remove him from CEO. He's already over spent on M&A that's failed with NASH and we got 3 phase 3's in 2018 that either hit big with the data or this stock tanks to $100. At that point shareholders will be after him!
Sure we have a few missteps but let that all fall on the shoulders of BS. His business acumen and leadership qualities combined with the value he has extracted from cyclosporine can not believe overlooked.
* can’t fall on his shoulders (sorry)
You are clueless!
This is where you are mistaken. He hasn't extracted value from Restasis. Everything was already in place regarding Restasis. The product was already almost at a billion dollars in sales before he became CEO. The patent extensions were already in place before he became CEO. The registrations in Europe were already planned before he became CEO. He has simply followed the course that was already in place regarding Restasis.
He developed the MD bottle with no preservative to extend our usage for years
Nope, the MDPF bottle was developed and the regulatory filing almost ready to be submitted before the takeover.